Lu Li
Stock Analyst at UBS
(2.33)
# 2,888
Out of 4,355 analysts
26
Total ratings
70%
Success rate
4.4%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lu Li
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QDEL QuidelOrtho | Rated: Hold | $17 → $12 | $13.02 | -7.83% | 7 | May 7, 2026 | |
| WAT Waters | Maintained: Hold | $330 → $375 | $383.57 | -2.23% | 2 | May 6, 2026 | |
| VCYT Veracyte | Maintained: Buy | $48 → $52 | $46.34 | +12.21% | 6 | May 6, 2026 | |
| DHR Danaher | Maintained: Buy | $250 | $182.67 | +36.86% | 1 | Apr 22, 2026 | |
| FLGT Fulgent Genetics | Maintained: Buy | $35 → $22 | $18.14 | +21.28% | 3 | Mar 2, 2026 | |
| MYGN Myriad Genetics | Maintained: Hold | $8 → $6 | $3.97 | +51.13% | 7 | Feb 25, 2026 |
QuidelOrtho
May 7, 2026
Rated: Hold
Price Target: $17 → $12
Current: $13.02
Upside: -7.83%
Waters
May 6, 2026
Maintained: Hold
Price Target: $330 → $375
Current: $383.57
Upside: -2.23%
Veracyte
May 6, 2026
Maintained: Buy
Price Target: $48 → $52
Current: $46.34
Upside: +12.21%
Danaher
Apr 22, 2026
Maintained: Buy
Price Target: $250
Current: $182.67
Upside: +36.86%
Fulgent Genetics
Mar 2, 2026
Maintained: Buy
Price Target: $35 → $22
Current: $18.14
Upside: +21.28%
Myriad Genetics
Feb 25, 2026
Maintained: Hold
Price Target: $8 → $6
Current: $3.97
Upside: +51.13%